Assessment of Measurable Residual Disease (MRD) in Chronic Lymphocytic Leukemia (CLL) and Multiple Myeloma (MM) Among US Community Hematologists/ Oncologists (cH/O)

被引：0
|
作者：
Gajra, Ajeet
Rathish, Yamini S.
Jeune-Smith, Yolaine
Klink, Andrew J.
Feinberg, Bruce
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-142005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Assessment of Minimal Residual Disease (MRD) in Chronic Lymphocytic Leukemia: A Review of the Data and Future Directions
    Mato, Anthony R.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (06) : 7 - 14
  • [22] The Evolving Use of Minimal Residual Disease (MRD) Assessment in Chronic Lymphocytic Leukemia: Q&A
    Cheson, Bruce D.
    Mato, Anthony R.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (06) : 15 - 20
  • [23] CD160: a novel approach to minimal residual disease (MRD) assessment in chronic lymphocytic leukaemia (CLL)
    Farren, T. W.
    Liu, F.
    Macey, M. G.
    Jenner, M.
    Prentice, A.
    Nathwani, A.
    Agrawal, S. G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 : 72 - 72
  • [24] Exome Sequencing in Chronic Lymphocytic Leukemia (CLL) and Multiple Myeloma (MM) Families Identifies Cosegregating Functional Variants
    Beiggi, Sara
    O'Brien, Daniel R.
    Achenbach, Sara J.
    Rabe, Kari G.
    Call, Timothy G.
    Kay, Neil E.
    Shanafelt, Tait D.
    Norman, Aaron D.
    Cunningham, Julie M.
    Rajkumar, Vincent
    Kumar, Shaji
    Cerhan, James R.
    Vachon, Celine M.
    Slager, Susan L.
    BLOOD, 2014, 124 (21)
  • [25] Using CD160 as a novel approach to the assessment of minimal residual disease (MRD) in chronic lymphocytic leukaemia (CLL)
    Farren, Timothy
    Giustiniani, Jerome
    Johansson, Ulrika
    Lim, Christina
    Athorn, Gemma
    Newland, Adrian
    Macey, Marion
    Agrawal, Samir
    BLOOD, 2007, 110 (11) : 606A - 606A
  • [26] MULTIDRUG RESISTANCE ASSOCIATED PARA-GLYCOPROTEIN IN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) AND IN MULTIPLE-MYELOMA (MM)
    DAMIANI, D
    BACCARANI, M
    RASPADORI, D
    MICHIELI, M
    MICHELUTTI, A
    GEROMIN, A
    RUSSO, D
    PATRIARCA, F
    VIRGOLINI, L
    REVIGNAS, MG
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 542 - 542
  • [27] Correlation of systemic and mucosal immunoglobulin (Ig) levels in patients (pts) with chronic lymphocytic leukemia (CLL) and multiple myeloma (MM).
    Morrison, VA
    Opstad, NL
    Janoff, EN
    CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) : 92 - 92
  • [28] Computational Flow Cytometry Provides Accurate and Sensitive Measurable Residual Disease Assessment in Chronic Lymphocytic Leukemia
    Nguyen, Phillip C.
    Vuong Nguyen
    Came, Neil
    Westerman, David A.
    BLOOD, 2022, 140 : 12369 - 12370
  • [29] CONTRADICTORY IMPACT OF SERUM BLYS LEVELS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), WALDESTROM'S MACROGLOBULINEMIA (WM) AND MULTIPLE MYELOMA (MM)
    Kyrtsonis, M. C.
    Sarris, K.
    Pangalis, G.
    Tzenou, T.
    Sachanas, S.
    Koulieris, E.
    Bartzis, V.
    Efthymiou, A.
    Dimou, M.
    Siakantaris, M.
    Vassilakopoulos, T.
    Angelopoulou, M.
    Panayiotidis, P.
    HAEMATOLOGICA, 2012, 97 : 301 - 301
  • [30] Systemic and mucosal immunoglobulin (Ig) levels and risk of infection patients (pts) with chronic lymphocytic leukemia (cll) and multiple myeloma (MM).
    Morrison, VA
    Hibbs, JR
    Janoff, EN
    BLOOD, 1996, 88 (10) : 948 - 948
12345